(Q41062372)

26 September 2017

A method for distinguishing benign from malignant breast lesions utilizing antibody present in normal human sera (English)

1 reference

10.1002/1097-0142(197906)43:6<2279::AID-CNCR2820430618>3.0.CO;2-O

https://api.crossref.org/works/10.1002/1097-0142(197906)43:6%3C2279::AID-CNCR2820430618%3E3.0.CO;2-O

12 April 2023

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A378352

12 April 2023

1 reference

10.1002/1097-0142(197906)43:6<2279::AID-CNCR2820430618>3.0.CO;2-O

https://api.crossref.org/works/10.1002/1097-0142(197906)43:6%3C2279::AID-CNCR2820430618%3E3.0.CO;2-O

12 April 2023

author name string

D. R. Howard

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A378352

12 April 2023

C. R. Taylor

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A378352

12 April 2023

language of work or name

English

0 references

publication date

1 June 1979

1 reference

full work available at URL

26 September 2017

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2F1097-0142(197906)43:6%3C2279::AID-CNCR2820430618%3E3.0.CO;2-O

1 reference

10.1002/1097-0142(197906)43:6<2279::AID-CNCR2820430618>3.0.CO;2-O

https://api.crossref.org/works/10.1002/1097-0142(197906)43:6%3C2279::AID-CNCR2820430618%3E3.0.CO;2-O

https://onlinelibrary.wiley.com/doi/full/10.1002/1097-0142(197906)43:6%3C2279::AID-CNCR2820430618%3E3.0.CO;2-O

12 April 2023

1 reference

10.1002/1097-0142(197906)43:6<2279::AID-CNCR2820430618>3.0.CO;2-O

https://api.crossref.org/works/10.1002/1097-0142(197906)43:6%3C2279::AID-CNCR2820430618%3E3.0.CO;2-O

12 April 2023

1 reference

26 September 2017

43

1 reference

26 September 2017

2279-2287

1 reference

26 September 2017

6

1 reference

Carcinoembryonic antigen (CEA) in patients with breast cancer

26 September 2017

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%28197906%2943%3A6%3C2279%3A%3AAID-CNCR2820430618%3E3.0.CO%3B2-O

21 January 2018

1

36

2124

Bali

1976

1 reference

10.1002/1097-0142(197906)43:6<2279::AID-CNCR2820430618>3.0.CO;2-O

https://api.crossref.org/works/10.1002/1097-0142(197906)43:6%3C2279::AID-CNCR2820430618%3E3.0.CO;2-O

Cellular responses to autologous breast cancer tissue. Sequential observations

12 April 2023

2

1 reference

10.1002/1097-0142(197906)43:6<2279::AID-CNCR2820430618>3.0.CO;2-O

https://api.crossref.org/works/10.1002/1097-0142(197906)43:6%3C2279::AID-CNCR2820430618%3E3.0.CO;2-O

Carcinoma in situ of the breast

12 April 2023

4

1 reference

10.1002/1097-0142(197906)43:6<2279::AID-CNCR2820430618>3.0.CO;2-O

https://api.crossref.org/works/10.1002/1097-0142(197906)43:6%3C2279::AID-CNCR2820430618%3E3.0.CO;2-O

Simultaneous assays of cancer associated antigens in benign and malignant breast diseases

12 April 2023

5

1 reference

10.1002/1097-0142(197906)43:6<2279::AID-CNCR2820430618>3.0.CO;2-O

https://api.crossref.org/works/10.1002/1097-0142(197906)43:6%3C2279::AID-CNCR2820430618%3E3.0.CO;2-O

Carcinoembryonic antigen in histopathology: immunoperoxidase staining of conventional tissue sections

12 April 2023

7

1 reference

10.1002/1097-0142(197906)43:6<2279::AID-CNCR2820430618>3.0.CO;2-O

https://api.crossref.org/works/10.1002/1097-0142(197906)43:6%3C2279::AID-CNCR2820430618%3E3.0.CO;2-O

Demonstration of cell-mediated immunity to human neoplasms of various histological types

12 April 2023

9

1 reference

10.1002/1097-0142(197906)43:6<2279::AID-CNCR2820430618>3.0.CO;2-O

https://api.crossref.org/works/10.1002/1097-0142(197906)43:6%3C2279::AID-CNCR2820430618%3E3.0.CO;2-O

Preneoplastic Lesions in the Human Breast

12 April 2023

13

1 reference

10.1002/1097-0142(197906)43:6<2279::AID-CNCR2820430618>3.0.CO;2-O

https://api.crossref.org/works/10.1002/1097-0142(197906)43:6%3C2279::AID-CNCR2820430618%3E3.0.CO;2-O

Relationship between carcinoembryonic antigen and blood group antigens A, B, and Lewis

12 April 2023

15

1 reference

10.1002/1097-0142(197906)43:6<2279::AID-CNCR2820430618>3.0.CO;2-O

https://api.crossref.org/works/10.1002/1097-0142(197906)43:6%3C2279::AID-CNCR2820430618%3E3.0.CO;2-O

Carcinoembryonic antigen: clinical and historical aspects

12 April 2023

16

1 reference

10.1002/1097-0142(197906)43:6<2279::AID-CNCR2820430618>3.0.CO;2-O

https://api.crossref.org/works/10.1002/1097-0142(197906)43:6%3C2279::AID-CNCR2820430618%3E3.0.CO;2-O

Staining of the A antigen human erythrocytes

12 April 2023

17

1 reference

10.1002/1097-0142(197906)43:6<2279::AID-CNCR2820430618>3.0.CO;2-O

https://api.crossref.org/works/10.1002/1097-0142(197906)43:6%3C2279::AID-CNCR2820430618%3E3.0.CO;2-O

Cell proliferation in normal human breast ducts, fibroadenomas, and other ductal hyperplasias measured by nuclear labeling with tritiated thymidine. Effects of menstrual phase, age, and oral contraceptive hormones

12 April 2023

18

1 reference

10.1002/1097-0142(197906)43:6<2279::AID-CNCR2820430618>3.0.CO;2-O

https://api.crossref.org/works/10.1002/1097-0142(197906)43:6%3C2279::AID-CNCR2820430618%3E3.0.CO;2-O

Immunofluorescence studies of benign and malignant human mammary tissue

12 April 2023

20

1 reference

10.1002/1097-0142(197906)43:6<2279::AID-CNCR2820430618>3.0.CO;2-O

https://api.crossref.org/works/10.1002/1097-0142(197906)43:6%3C2279::AID-CNCR2820430618%3E3.0.CO;2-O

Histologic changes in incipient carcinoma of the breast

12 April 2023

21

1 reference

10.1002/1097-0142(197906)43:6<2279::AID-CNCR2820430618>3.0.CO;2-O

https://api.crossref.org/works/10.1002/1097-0142(197906)43:6%3C2279::AID-CNCR2820430618%3E3.0.CO;2-O

Carcinoma-associated blood group MN precursor antigens against which all humans possess antibodies

12 April 2023

23

1 reference

10.1002/1097-0142(197906)43:6<2279::AID-CNCR2820430618>3.0.CO;2-O

https://api.crossref.org/works/10.1002/1097-0142(197906)43:6%3C2279::AID-CNCR2820430618%3E3.0.CO;2-O

Blood group MN precursors as human breast carcinoma-associated antigens and "naturally" occurring human cytotoxins against them

12 April 2023

24

1 reference

10.1002/1097-0142(197906)43:6<2279::AID-CNCR2820430618>3.0.CO;2-O

https://api.crossref.org/works/10.1002/1097-0142(197906)43:6%3C2279::AID-CNCR2820430618%3E3.0.CO;2-O

Status of blood group carbohydrate chains in ontogenesis and in oncogenesis

12 April 2023

26

1 reference

10.1002/1097-0142(197906)43:6<2279::AID-CNCR2820430618>3.0.CO;2-O

https://api.crossref.org/works/10.1002/1097-0142(197906)43:6%3C2279::AID-CNCR2820430618%3E3.0.CO;2-O

12 April 2023

Identifiers

10.1002/1097-0142(197906)43:6<2279::AID-CNCR2820430618>3.0.CO;2-O

1 reference

26 September 2017

1 reference